$92.3 Billion is the total value of Baillie Gifford's 705 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 9.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GOOG | Buy | Alphabet Inc Class Ccap stk cl c | $2,946,643,000 | -12.4% | 2,534,070 | +0.7% | 3.19% | -1.8% |
MELI | Buy | MercadoLibre | $2,274,303,000 | -9.7% | 4,654,923 | +5.7% | 2.46% | +1.3% |
DXCM | Buy | Dexcom Inc | $1,300,723,000 | +23.5% | 4,830,552 | +0.3% | 1.41% | +38.4% |
ZM | Buy | Zoom Video Communications Inccl a | $1,047,612,000 | +525.0% | 7,169,538 | +191.0% | 1.14% | +600.6% |
PDD | Buy | Pinduoduo Inc ADRsponsored ads | $982,007,000 | +53.2% | 27,255,238 | +60.8% | 1.06% | +71.6% |
WDAY | Buy | Workday Inccl a | $918,814,000 | +7.4% | 7,055,860 | +35.6% | 1.00% | +20.3% |
ALNY | Buy | Alnylam Pharmaceuticals | $915,621,000 | -2.9% | 8,411,769 | +2.7% | 0.99% | +8.9% |
TDOC | Buy | Teladoc | $895,028,000 | +86.5% | 5,774,002 | +0.7% | 0.97% | +109.1% |
AJG | Buy | AJ Gallagher & Co | $586,521,000 | -9.0% | 7,195,689 | +6.3% | 0.64% | +1.9% |
BIDU | Buy | Baidu.com Sponsored ADRspon adr rep a | $525,489,000 | -19.9% | 5,213,705 | +0.4% | 0.57% | -10.3% |
MLM | Buy | Martin Marietta Materials | $518,324,000 | -32.0% | 2,739,119 | +0.5% | 0.56% | -23.7% |
SGEN | Buy | Seattle Genetics | $493,919,000 | +1.6% | 4,280,810 | +0.6% | 0.54% | +13.8% |
PTON | Buy | Peloton Interactive Inc | $463,708,000 | +18.8% | 17,465,459 | +27.1% | 0.50% | +33.2% |
TER | Buy | Teradyne | $443,375,000 | -20.6% | 8,184,879 | +0.0% | 0.48% | -10.9% |
Z | Buy | Zillow Group Inc Class Ccl c cap stk | $407,653,000 | -21.5% | 11,317,386 | +0.1% | 0.44% | -12.0% |
RYAAY | Buy | Ryanair ADRsponsored adr ne | $399,771,000 | -32.9% | 7,530,081 | +10.8% | 0.43% | -24.7% |
ABMD | Buy | Abiomed | $395,761,000 | -14.7% | 2,726,380 | +0.2% | 0.43% | -4.2% |
SE | Buy | SEA Ltd ADRadr | $372,690,000 | +353.4% | 8,410,972 | +311.6% | 0.40% | +411.4% |
NIO | Buy | NIO Inc ADRspon ads | $282,849,000 | -30.6% | 101,744,131 | +0.4% | 0.31% | -22.3% |
BAP | Buy | Credicorp | $273,852,000 | -31.6% | 1,914,104 | +1.9% | 0.30% | -23.3% |
JD | Buy | JD.Com Inc - ADRspon adr cl a | $259,051,000 | +47.0% | 6,396,323 | +27.9% | 0.28% | +65.3% |
WSO | Buy | Watsco Inc | $253,506,000 | -12.2% | 1,604,162 | +0.1% | 0.28% | -1.4% |
VALE | Buy | Vale SA ADRadr | $253,148,000 | -35.4% | 30,536,600 | +2.9% | 0.27% | -27.7% |
WUBA | Buy | 58.Com Inc Adrspon adr rep a | $216,851,000 | -24.6% | 4,450,959 | +0.1% | 0.24% | -15.5% |
TME | Buy | Tencent Music Entertainment ADRsponsored ads | $203,825,000 | +7.4% | 20,260,972 | +25.4% | 0.22% | +20.8% |
ITUB | Buy | Itau Unibanco Holding SA-ADRspon adr rep pfd | $189,405,000 | -50.6% | 42,184,011 | +0.6% | 0.20% | -44.7% |
GOOGL | Buy | Alphabet Inc Class Acap stk cl a | $178,706,000 | -6.4% | 153,798 | +7.9% | 0.19% | +5.4% |
PBR | Buy | Petrobras Common ADRsponsored adr | $178,209,000 | -59.4% | 32,401,631 | +17.7% | 0.19% | -54.5% |
HHC | Buy | Howard Hughes | $169,576,000 | -16.9% | 3,356,603 | +108.6% | 0.18% | -6.6% |
ZLAB | Buy | Zai Lab ADRadr | $160,349,000 | +26.8% | 3,114,800 | +2.5% | 0.17% | +42.6% |
DNLI | Buy | Denali Therapeutics | $159,861,000 | +20.9% | 9,129,752 | +20.3% | 0.17% | +35.2% |
CPA | Buy | Copa Holdings S Acl a | $142,878,000 | -58.0% | 3,154,744 | +0.2% | 0.16% | -52.9% |
MYGN | Buy | Myriad Genetics Inc | $128,360,000 | -47.4% | 8,970,006 | +0.1% | 0.14% | -41.1% |
BBD | Buy | Banco Bradesco Pn ADRsp adr pfd new | $119,244,000 | -54.0% | 29,370,158 | +1.5% | 0.13% | -48.4% |
GKOS | Buy | Glaukos Corp | $112,447,000 | -42.3% | 3,643,752 | +1.9% | 0.12% | -35.1% |
YEXT | Buy | Yext Inc | $108,870,000 | -28.7% | 10,683,923 | +0.9% | 0.12% | -20.3% |
MRNA | Buy | Moderna Inc | $106,619,000 | +59.6% | 3,559,884 | +4.2% | 0.12% | +78.5% |
LYFT | Buy | Lyft Inc Class A Common | $100,067,000 | -36.9% | 3,726,896 | +1.1% | 0.11% | -29.4% |
STAA | Buy | Staar Surgical | $63,504,000 | -7.1% | 1,968,516 | +1.3% | 0.07% | +4.5% |
GRFS | New | Grifols ADRsp adr rep b nvt | $63,958,000 | – | 3,175,697 | +100.0% | 0.07% | – |
AVAV | Buy | Aerovironment | $50,373,000 | -0.2% | 826,330 | +1.1% | 0.06% | +12.2% |
PCRX | Buy | Pacira BioSciences | $47,341,000 | -24.7% | 1,411,892 | +1.8% | 0.05% | -16.4% |
CDXS | Buy | Codexis | $45,615,000 | -24.7% | 4,087,317 | +7.9% | 0.05% | -16.9% |
SPLK | Buy | Splunk Inc | $45,224,000 | -14.6% | 358,263 | +1.4% | 0.05% | -3.9% |
MMYT | Buy | MakeMyTrip | $43,006,000 | -43.2% | 3,597,299 | +8.8% | 0.05% | -35.6% |
EXAS | Buy | Exact Sciences | $42,323,000 | -36.5% | 729,707 | +1.3% | 0.05% | -28.1% |
BZUN | Buy | Baozun Spn Adr 1:1sponsored adr | $39,120,000 | -14.7% | 1,400,159 | +1.2% | 0.04% | -4.5% |
BL | Buy | Blackline | $36,490,000 | +3.1% | 693,592 | +1.1% | 0.04% | +17.6% |
BGNE | Buy | Beigene Ltdsponsored adr | $37,182,000 | -22.3% | 302,023 | +4.6% | 0.04% | -13.0% |
TRUP | Buy | Trupanion | $36,151,000 | -29.9% | 1,388,782 | +0.8% | 0.04% | -22.0% |
IRBT | Buy | iRobot | $33,671,000 | -18.5% | 823,274 | +0.9% | 0.04% | -10.0% |
IPGP | Buy | IPG Photonics Corp | $32,391,000 | -23.0% | 293,708 | +1.2% | 0.04% | -14.6% |
UPS | Buy | United Parcel Servicecl b | $32,389,000 | -19.4% | 346,702 | +1.0% | 0.04% | -10.3% |
CYBR | New | CyberArk Software Ltd | $30,156,000 | – | 352,448 | +100.0% | 0.03% | – |
NATI | Buy | National Instruments Corp | $29,717,000 | -21.1% | 898,340 | +1.0% | 0.03% | -11.1% |
WORK | Buy | Slack Technologies Inc | $28,169,000 | +168.4% | 1,049,526 | +124.8% | 0.03% | +210.0% |
RAMP | Buy | Liveramp Holdings Inc | $26,751,000 | -30.7% | 812,600 | +1.2% | 0.03% | -21.6% |
PBRA | Buy | Petrobras Pref ADRsp adr non vtg | $26,658,000 | -62.3% | 4,945,837 | +4.3% | 0.03% | -57.4% |
JMIA | Buy | Jumia Technologies Ag ADRsponsored ads | $27,001,000 | -56.6% | 9,246,855 | +0.1% | 0.03% | -51.7% |
EB | Buy | Eventbrite Inc Class A | $23,195,000 | -63.1% | 3,177,353 | +1.9% | 0.02% | -59.0% |
AMBA | Buy | Ambarella | $20,289,000 | -18.9% | 417,810 | +1.2% | 0.02% | -8.3% |
XYL | Buy | Xylem | $20,553,000 | +11.5% | 315,560 | +34.9% | 0.02% | +22.2% |
RUBY | Buy | Rubius Therapeutics Inc | $18,943,000 | -53.1% | 4,256,900 | +0.1% | 0.02% | -46.2% |
FTCH | Buy | Farfetch | $18,198,000 | -14.1% | 2,303,432 | +12.5% | 0.02% | 0.0% |
FARO | Buy | Faro Technologies | $18,861,000 | -10.8% | 423,843 | +0.9% | 0.02% | 0.0% |
EVER | Buy | EverQuote Inc | $16,656,000 | -22.7% | 634,505 | +1.2% | 0.02% | -14.3% |
ECL | Buy | Ecolab | $13,398,000 | +9.6% | 85,975 | +35.7% | 0.02% | +25.0% |
DE | New | Deere & Co | $13,747,000 | – | 99,496 | +100.0% | 0.02% | – |
SSYS | Buy | Stratasys | $13,756,000 | -20.5% | 862,489 | +0.9% | 0.02% | -11.8% |
INFY | Buy | Infosys Ltd ADRsponsored adr | $13,816,000 | -16.4% | 1,682,780 | +5.1% | 0.02% | -6.2% |
ADAP | Buy | Adaptimmune Therapeutics ADRsponds adr | $11,843,000 | +130.2% | 4,354,023 | +1.6% | 0.01% | +160.0% |
ADRO | Buy | Aduro Biotechnology | $11,725,000 | +134.7% | 4,279,324 | +1.1% | 0.01% | +160.0% |
VECO | Buy | Veeco Instruments | $12,057,000 | -33.6% | 1,259,935 | +1.9% | 0.01% | -27.8% |
CEVA | Buy | CEVA Inc | $11,095,000 | -6.7% | 445,043 | +0.9% | 0.01% | +9.1% |
AXGN | Buy | Axogen Inc | $10,843,000 | -41.3% | 1,042,530 | +1.0% | 0.01% | -33.3% |
TROW | New | T. Rowe Price | $10,749,000 | – | 110,072 | +100.0% | 0.01% | – |
ZUO | Buy | Zuora Inc Class A | $9,755,000 | -43.3% | 1,211,688 | +1.0% | 0.01% | -35.3% |
UPWK | Buy | Upwork Inc | $8,834,000 | -38.3% | 1,369,700 | +2.0% | 0.01% | -28.6% |
DMRC | Buy | Digimarc | $9,547,000 | -60.6% | 731,574 | +1.3% | 0.01% | -56.5% |
BNFT | Buy | Benefitfocus Inc | $8,152,000 | -58.8% | 915,048 | +1.4% | 0.01% | -52.6% |
HUYA | New | HUYA ADR | $7,810,000 | – | 460,755 | +100.0% | 0.01% | – |
HCM | Buy | Hutchison China Meditechsponsored adr | $3,920,000 | -28.2% | 219,605 | +0.8% | 0.00% | -20.0% |
KEP | Buy | Korea Electric Power ADRsponsored adr | $1,032,000 | -10.3% | 136,800 | +40.6% | 0.00% | 0.0% |
SAGE | Buy | Sage Therapeutics Inc | $25,000 | -28.6% | 879 | +79.4% | 0.00% | – |
WPM | Buy | Wheaton Precious Metals | $195,000 | +23.4% | 7,073 | +33.2% | 0.00% | – |
HCAT | Buy | Health Catalyst Inc | $88,000 | +2.3% | 3,352 | +34.5% | 0.00% | – |
MBT | Buy | Mobile Telesystems ADRsponsored adr | $195,000 | -8.9% | 25,700 | +21.8% | 0.00% | – |
MNLO | New | Menlo Therapeutics Inc | $349,000 | – | 129,971 | +100.0% | 0.00% | – |
BBIO | New | BridgeBio Pharma Inc | $78,000 | – | 2,700 | +100.0% | 0.00% | – |
TXG | New | 10X Genomics Inc Class A | $99,000 | – | 1,589 | +100.0% | 0.00% | – |
ARI | Buy | Apollo Commercial Real Estate Finance REIT | $110,000 | -50.2% | 14,800 | +22.3% | 0.00% | – |
NLY | Buy | Annaly Capital Man. | $110,000 | -34.1% | 21,682 | +22.1% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-08
About Baillie Gifford
Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.
Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.
One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.
Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Amazon.Com | 42 | Q3 2023 | 10.0% |
Tesla Motors | 42 | Q3 2023 | 10.7% |
Illumina | 42 | Q3 2023 | 6.6% |
Baidu.com Sponsored ADR | 42 | Q3 2023 | 11.6% |
Meta Platforms Inc | 42 | Q3 2023 | 5.0% |
MercadoLibre | 42 | Q3 2023 | 7.3% |
Intuitive Surgical | 42 | Q3 2023 | 3.5% |
Moody's Corp | 42 | Q3 2023 | 1.4% |
MasterCard Inc-Class A | 42 | Q3 2023 | 1.9% |
Workday Inc | 42 | Q3 2023 | 1.4% |
View Baillie Gifford's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Oddity Tech Ltd | September 07, 2023 | 4,914,661 | 10.9% |
Roblox Corp | September 07, 2023 | 28,106,215 | 5.0% |
SiteOne Landscape Supply, Inc. | August 03, 2023 | 2,234,985 | 5.0% |
UPWORK, INC | August 03, 2023 | 6,565,230 | 4.9% |
CHINOOK THERAPEUTICS, INC. | August 01, 2023 | 844,684 | 2.0% |
MELI Kaszek Pioneer CorpSold out | July 05, 2023 | 0 | 0.0% |
Abcam plc | June 08, 2023 | 11,331,726 | 4.9% |
CARVANA CO. | June 06, 2023 | 61,989 | 0.1% |
EverQuote, Inc. | May 03, 2023 | 1,358,439 | 5.0% |
CEMEX SAB DE CV | March 03, 2023 | 752,914,110 | 5.0% |
View Baillie Gifford's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-04-04 |
SC 13G/A | 2024-04-04 |
SC 13G/A | 2024-03-07 |
SC 13G/A | 2024-03-06 |
SC 13G/A | 2024-02-07 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-01-30 |
SC 13G/A | 2024-01-30 |
SC 13G/A | 2024-01-30 |
View Baillie Gifford's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.